Wolverine Asset Management’s Emergent Biosolutions EBS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.12M | Buy |
174,933
+38,600
| +28% | +$246K | 0.01% | 395 |
|
2025
Q1 | $663K | Hold |
136,333
| – | – | 0.01% | 511 |
|
2024
Q4 | $1.3M | Buy |
+136,333
| New | +$1.3M | 0.01% | 367 |
|
2021
Q4 | – | Sell |
-2,695
| Closed | -$134K | – | 1777 |
|
2021
Q3 | $134K | Hold |
2,695
| – | – | ﹤0.01% | 977 |
|
2021
Q2 | $169K | Sell |
2,695
-3,856
| -59% | -$242K | ﹤0.01% | 1106 |
|
2021
Q1 | $608K | Buy |
+6,551
| New | +$608K | 0.01% | 673 |
|
2018
Q4 | – | Sell |
-1,498
| Closed | -$98K | – | 1140 |
|
2018
Q3 | $98K | Hold |
1,498
| – | – | ﹤0.01% | 861 |
|
2018
Q2 | $75K | Hold |
1,498
| – | – | ﹤0.01% | 820 |
|
2018
Q1 | $78K | Hold |
1,498
| – | – | ﹤0.01% | 845 |
|
2017
Q4 | $69K | Buy |
+1,498
| New | +$69K | ﹤0.01% | 775 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 902 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 859 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 715 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 732 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 716 |
|
2016
Q1 | – | Hold |
0
| – | – | – | 825 |
|